Vaxfab Enterprises Complete Financial Statements
In FY2026, Vaxfab Enterprises (VEL) reported revenue ₹12 Cr, net profit ₹-3 Cr and EPS ₹-3.85, with a net profit margin of -25.0% and ROE of -6.8%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see VEL stock price BSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
VEL Revenue, Net Profit & EBITDA — Year-on-Year Growth
VEL YoY (Mar 2025 vs Mar 2026) — revenue -76.9%, net profit -175.0%, EBITDA -160.0%, expenses -68.1%. View VEL yearly price range for the annual high/low range and current price position.
VEL Income Statement — Revenue, EBITDA & Net Profit
Vaxfab Enterprises revenue ₹12 Cr, EBITDA ₹-3 Cr, net profit ₹-3 Cr, EPS ₹-3.85 (2026) — net profit margin -25.0%. Check Vaxfab Enterprises market cap to track the company's total market size over time.
| Particulars | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Dec 2024 | Mar 2023 | Jun 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 4 | 52 | 52 | 61 | 12 | 46 | 14 | 4 | 0 | 0 | 0 | 2 |
| Expenses | 15 | 6 | 54 | 47 | 51 | 15 | 39 | 14 | 4 | 0 | 0 | 0 | 2 |
| EBITDA | -3 | -2 | -3 | 5 | 10 | -3 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 2.00% | -1413.00% | 1.00% | 8.00% | -14.00% | 2.00% | 14.00% | 2.00% | 6.00% | -12.00% | 33.00% | 31.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -3 | -2 | -3 | 5 | 6 | -3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 1 | -1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -3 | -3 | -2 | 4 | 4 | -3 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | -3.85 | -1.20 | -0.27 | 0.48 | 49.07 | -0.39 | 0.76 | 0.33 | 0.31 | 0.01 | 0.88 | 0.02 | 0.85 |
VEL Balance Sheet — Assets, Liabilities & Shareholders' Equity
VEL total assets ₹204 Cr, total equity ₹44 Cr, total liabilities ₹ Cr (2026) — ROE -6.8%.
| Particulars | 2026 | 2023 | 2022 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 204 | 27 | 3 |
| Current Assets | 168 | 14 | 2 |
| Fixed Assets | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 7 | 12 | 0 |
| Other Assets | 0 | 14 | 3 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 1 | 0 | 0 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 44 | 17 | 3 |
| Share Capital | 40 | 9 | 2 |
| Reserves & Surplus | 4 | 8 | 2 |
VEL Cash Flow Statement — Operating, Investing & Financing
Vaxfab Enterprises operating cash flow ₹2 Cr, investing ₹-12 Cr, financing ₹14 Cr, net cash flow ₹4 Cr (2023).
| Particulars | March 2023 | March 2022 |
|---|---|---|
| Operating Activities | 2 | 0 |
| Investing Activities | -12 | 0 |
| Financing Activities | 14 | 0 |
| Net Cash Flow | 4 | 0 |